| Peer-Reviewed

New Approaches in Coronary Atherosclerotic Disease: A Brief Overview

Received: 14 October 2022     Accepted: 31 October 2022     Published: 29 December 2022
Views:       Downloads:
Abstract

Coronary atherosclerotic disease is a pathology of great prevalence in the Western population and that accompanies the human being from intrauterine stage until the end of life. In young people necropsies from Korea and Vietnam wars it was found a 12 to 20% of coronary arteries narrowing in people under 26 years old otherwise healthy. Many traditional treatments in this illness have been considered but in the last years new approaches have appeared and promise a very interesting point of view in coronary disease such as omega 3 oils or antioxidant compounds that could work resetting ischemic tissue disorders. For instance Diabetes Mellitus is a disease very relationed to coronary disease through the formation of AGES. These are proteins modified and altered by glucose. In a hyperglicemic state there are many glucose particles fusioned to proteins; In the beginning this occurs in a reversible way but later the glucose becomes an integral part of proteins. AGES will be- accompanied by Oxygen free radicals- the originators of diabetic complications such as coronary artery disease. Evidently we need to learn more about this illness in order to get a better comprehension of physiopathologic mechanisms involucrated and try to stop or slow its progress. In this briefly monography we try to go through some of these statements.

Published in Cardiology and Cardiovascular Research (Volume 6, Issue 4)
DOI 10.11648/j.ccr.20220604.16
Page(s) 124-129
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Cell Adhesion Molecules, Oxidative Stress, Insulin Resistance, Resveratrol

References
[1] Gurfinkel EP. La enfermedad coronaria. 1ed, Buenos Aires: Journal, 2008.
[2] Lizarzaburu Robles JC. Sindrome metabolico: concepto y aplicación practica. An Fac Med. 2013; 74 (4): 315-20.
[3] Garcia Moll X, Kaski JC. Cardiopatia Isquemica: Marcadores de inflamación y riesgo cardiovascular. Rev Cubana Med 2000; 39 (2): 120-40.
[4] Suarez Robalino A. Aterosclerosis y marcadores de inflamacion. Rev. Med. FCM-UCSG. Año 2011, Vol. 17 No. 4: Pags 280-284.
[5] Dandona P, Karne R, Ghanim H, Hamouda W, Aljada A, Magsino CH. Carvedilol inhibits Reactive Oxigen Species generation by leukocytes and oxidative damage to amino acids. Circulation 2000; 101; 122- 124.
[6] Ganong WF. Fisiologia Medica. Editorial El Manual Moderno, 2004.
[7] Ridker PM, Cannon Ch P, Morrow D, Rifai N, Rose LM, Mc Cabe C, Pfeffer MA, Braunwald E. C- Reactive Protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20-8.
[8] Rizos E, Kostoula A, Elisaf M, Mikhailidis DP. Effect of Ciprofibrate on C-Reactive Protein and Fibrinogen levels. Angiology 53: 273-277, 2002.
[9] Chen JW, Lin FY, Chen YH, Wu T-Ch, Chen Y-L, Lin SJ. Carvedilol inhibits Tumor Necrosis Factor-a-induced Endothelial Transcription Factor activation, Adhesion Molecule expression, and adhesiveness to human mononuclear cells. Arterioscler Thromb Vasc Biol. 2004; 24: 2075-2081.
[10] Velez-Marin M, Uribe Velasquez LF, Lenz Souza MI. Papel del resveratrol de uva como antioxidante. 2011-09-27 (Rev. 2012-01-06).
[11] Elejalde Guerra JI. Estres oxidativo, enfermedades y tratamientos antioxidantes. An. Med. Interna [Madrid] vol. 18 no. 6 Jun. 2001.
[12] Corrales LC, Munoz Ariza MM. Estres Oxidativo origen, evolucion y consecuencias de la toxicidad del oxigeno. Publicacion cientifica en Ciencias Biomedicas-Issn. 1794-2470- Vol. 10 No. 18. 2012.
[13] Suarez Robalino A. Dislipidemias y el aceite Sacha Inchi. editorial.ucsg.edu.ec. Vol 20, No 2, 2016. pags 91-96.
[14] Lopez Farre A, Macaya C. Efectos antitromboticos y antiinflamatorios de los acidos grasos omega-3. Rev Esp Cardiol Supl 2006; 6 31D-7D.
[15] Gambini J, Lopez-grueso R, Olaso-Gonzalez G, Ingles M, Abdelazid K, El Alami M, Bonet-Costa V, Vina J, Borras C. Resveratrol: distribución, propiedades y perpectivas. Revista Española de Geriatria y Gerontologia, Vol. 48. Num 2: pags 79-88; 2013.
[16] Langsjoen PH, Langsjoen AM [2008]. Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors 32 [1-4]: 119-28. PMID 19096107.
[17] Ishikawa A, Kawarazaki H, Ando K, Fujita M, Fujita T, Homma Y [Feb 2011]. Renal preservation effect of ubiquinol, the reduced form of coenzyme Q 10. Clin. Exp. Nephrol: 15 [1]; 30-3.
[18] Gholnari T, Aghadavod E, Soleimani A, Al Hamidi G, Sharifi N. The effects of Coenzyme supplementation on glucose metabolism, lipid profiles, inflammation, and oxidative stress in patients with diabetic nephropathy. A randomized, double blind placebo controlled trial. J Am Coll Nutr. Mar-Apr 2018; 37 [3]: 188-193.
[19] Raygan F, Rezavandi Z, Dadkhah Tehrani S, Farrokhian A, Asemi Z. The effects of coenzyme Q-10 adminitration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome. Eur J Nutr. 2016 Dec; 55 [8]: 2357-2364.
Cite This Article
  • APA Style

    Alejandro Suarez. (2022). New Approaches in Coronary Atherosclerotic Disease: A Brief Overview. Cardiology and Cardiovascular Research, 6(4), 124-129. https://doi.org/10.11648/j.ccr.20220604.16

    Copy | Download

    ACS Style

    Alejandro Suarez. New Approaches in Coronary Atherosclerotic Disease: A Brief Overview. Cardiol. Cardiovasc. Res. 2022, 6(4), 124-129. doi: 10.11648/j.ccr.20220604.16

    Copy | Download

    AMA Style

    Alejandro Suarez. New Approaches in Coronary Atherosclerotic Disease: A Brief Overview. Cardiol Cardiovasc Res. 2022;6(4):124-129. doi: 10.11648/j.ccr.20220604.16

    Copy | Download

  • @article{10.11648/j.ccr.20220604.16,
      author = {Alejandro Suarez},
      title = {New Approaches in Coronary Atherosclerotic Disease: A Brief Overview},
      journal = {Cardiology and Cardiovascular Research},
      volume = {6},
      number = {4},
      pages = {124-129},
      doi = {10.11648/j.ccr.20220604.16},
      url = {https://doi.org/10.11648/j.ccr.20220604.16},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20220604.16},
      abstract = {Coronary atherosclerotic disease is a pathology of great prevalence in the Western population and that accompanies the human being from intrauterine stage until the end of life. In young people necropsies from Korea and Vietnam wars it was found a 12 to 20% of coronary arteries narrowing in people under 26 years old otherwise healthy. Many traditional treatments in this illness have been considered but in the last years new approaches have appeared and promise a very interesting point of view in coronary disease such as omega 3 oils or antioxidant compounds that could work resetting ischemic tissue disorders. For instance Diabetes Mellitus is a disease very relationed to coronary disease through the formation of AGES. These are proteins modified and altered by glucose. In a hyperglicemic state there are many glucose particles fusioned to proteins; In the beginning this occurs in a reversible way but later the glucose becomes an integral part of proteins. AGES will be- accompanied by Oxygen free radicals- the originators of diabetic complications such as coronary artery disease. Evidently we need to learn more about this illness in order to get a better comprehension of physiopathologic mechanisms involucrated and try to stop or slow its progress. In this briefly monography we try to go through some of these statements.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - New Approaches in Coronary Atherosclerotic Disease: A Brief Overview
    AU  - Alejandro Suarez
    Y1  - 2022/12/29
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ccr.20220604.16
    DO  - 10.11648/j.ccr.20220604.16
    T2  - Cardiology and Cardiovascular Research
    JF  - Cardiology and Cardiovascular Research
    JO  - Cardiology and Cardiovascular Research
    SP  - 124
    EP  - 129
    PB  - Science Publishing Group
    SN  - 2578-8914
    UR  - https://doi.org/10.11648/j.ccr.20220604.16
    AB  - Coronary atherosclerotic disease is a pathology of great prevalence in the Western population and that accompanies the human being from intrauterine stage until the end of life. In young people necropsies from Korea and Vietnam wars it was found a 12 to 20% of coronary arteries narrowing in people under 26 years old otherwise healthy. Many traditional treatments in this illness have been considered but in the last years new approaches have appeared and promise a very interesting point of view in coronary disease such as omega 3 oils or antioxidant compounds that could work resetting ischemic tissue disorders. For instance Diabetes Mellitus is a disease very relationed to coronary disease through the formation of AGES. These are proteins modified and altered by glucose. In a hyperglicemic state there are many glucose particles fusioned to proteins; In the beginning this occurs in a reversible way but later the glucose becomes an integral part of proteins. AGES will be- accompanied by Oxygen free radicals- the originators of diabetic complications such as coronary artery disease. Evidently we need to learn more about this illness in order to get a better comprehension of physiopathologic mechanisms involucrated and try to stop or slow its progress. In this briefly monography we try to go through some of these statements.
    VL  - 6
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Medicine Faculty, Catholic University, Guayaquil, Ecuador

  • Sections